2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Stomach Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
3
Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Testicular Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms, Unknown Primary
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Adrenal Gland Neoplasms
2
Vaginal Neoplasms
1
Uterine Neoplasms
1
Thymus Neoplasms
1
Solitary Fibrous Tumors
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Penile Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Tamoxifen
25
Radiotherapy
15
Chemotherapy, Adjuvant
11
Anastrozole
11
Specimen Handling
10
Neoadjuvant Therapy
8
Letrozole
8
Biopsy
7
Radiation
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
Immunohistochemistry
5
Gene Expression Profiling
5
exemestane
4
Surgical Procedures, Operative
4
Sentinel Lymph Node Biopsy
4
Radiotherapy, Intensity-Modulated
4
Radiotherapy, Conformal
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Early Intervention, Educational
4
Counseling
4
afimoxifene
3
Trastuzumab
3
Surveys and Questionnaires
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation Dose Hypofractionation
3
Methods
3
Mastectomy
3
High-Energy Shock Waves
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
FAPI-46
×
Clear all
NCT06540872
2026-06-03
MI-CISDIR
Universität Münster
Phase 2
Recruiting
30 enrolled